Daily non-political popular news in brief.
Chemotherapy appears to delay cancer recurrence following surgery for pancreatic cancer
01-16-2007 · EurekAlert!Use of the drug gemcitabine for chemotherapy significantly delays the recurrence of cancer, compared to no chemotherapy, for patients following pancreatic cancer surgery, according to a study in the January 17 issue of JAMA.
Read more »
Keywords: chemotherapy, appears, delay, cancer, recurrence, following, surgery, pancreatic, appear
« Previous | Next »
Similar news on "Chemotherapy appears to delay cancer recurrence following surgery for pancreatic cancer":
- Chemotherapy drug shrinks brain tumors
05-21-2007 · EurekAlert!
Cancerous brain tumors appear to respond favorably to the drug temozolomide when used as primary chemotherapy after surgery, and the treatment appears to work best in people missing a certain gene, according to a study published in the May 22, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
Similar news · Read more »
- Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
06-22-2007 · EurekAlert!
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation.
Similar news · Read more »
- Mayo Clinic Cancer Center -- Surgery and adjuvant therapy may work for pancreatic cancer
01-20-2007 · EurekAlert!
In the largest single-institution retrospective study to date, researchers at Mayo Clinic Cancer Center have shown that giving patients both radiation and chemotherapy after completely removing invasive pancreatic cancer may improve overall survival rates.
Similar news · Read more »
- GSK announces launch of largest ever Phase III trial in lung cancer treatment
06-05-2007 · EurekAlert!
GlaxoSmithKline today announced final results of a Phase II clinical trial of its investigational Antigen-Specific Cancer Immunotherapeutic MAGE-A3 in non small cell lung cancer. Final trial analysis showed a 27 percent reduction in the relative risk of cancer recurrence following surgery, compared to placebo. GSK also announced today the launch of a Phase III efficacy and safety trial for this novel cancer immunotherapy; the largest clinical trial ever conducted in lung cancer treatment.
Similar news · Read more »
- First biomarker discovered that predicts prostate cancer outcome
08-15-2007 · EurekAlert!
Mayo Clinic researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery.
Similar news · Read more »
- Clinical trial evaluating brain cancer vaccine is underway at NYU
10-18-2007 · EurekAlert!
A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center. The study will evaluate the addition of the vaccine following standard therapy with surgery and chemotherapy in patients with glioblastoma multiforme, a deadly form of brain cancer.
Similar news · Read more »
- Report calls for using heated chemotherapy after colon cancer surgery to optimize patient survival
11-03-2006 · EurekAlert!
There is new hope for some of the most seriously ill colon cancer patients today, following the release of a consensus statement by 72 leading oncology surgeons from 14 countries, including the United States. The Peritoneal Surface Malignancy Group (PSMG) has concluded that surgery, followed by heated chemotherapy delivered through the lower abdomen of the patient before leaving the operating room, may significantly increase the life expectancy for patients with Stage IV colorectal cancer.
Similar news · Read more »
- Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
09-27-2007 · EurekAlert!
Giving pancreatic cancer patients the chemotherapy drug gemcitabine after surgery delays progression of the disease by about six months, according to new research by Japanese scientists.
Similar news · Read more »
- Taxol-type drugs give slight boost to survival rates in early breast cancer
10-16-2007 · EurekAlert!
The breast cancer drugs called taxanes, which include taxol and taxotere, increase survival rates when used as part of chemotherapy following surgery for cancers that have not spread, according to a new review of the research.
Similar news · Read more »
- Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
07-17-2007 · EurekAlert!
Combining pre-operative chemotherapy and surgery increases the average chance of survival at five years by approximately 6 percent compared with surgery alone.
Similar news · Read more »
